Today’s Solutions: December 14, 2024

The inability to detect Alzheimer’s early is one main reason pharmaceutical companies have not been able to develop a drug to combat the disease, which is the most common form of dementia. That’s why it’s great news that researchers have just developed a simple blood test that shows evidence of brain damage due to Alzheimer’s almost seven years before any kind of cognitive change occurs. Theoretically, this test could be used to find patients who will go on to develop the disease, so that in the near future they could be enrolled in drug trials, and in the long term, could be saved from developing dementia.

Solutions News Source Print this article
More of Today's Solutions

This beautiful concrete home has trees spilling out the windows

We don’t typically publish stories about the design of individual homes, but sometimes you need to give credit where it’s due. In Ha Long, ...

Read More

Americans are finally starting to embrace the bidet

Bidet sales are up in America! Editorial confession: We’ve been hoping to write something like that for a long time. If you don’t know ...

Read More

New implant cools nerves and cuts pain, reducing opioid need

In response to the ongoing opioid epidemic, medical researchers are developing viable alternatives to pain management. While opioids have proven effective at managing pain, ...

Read More

Tova Friedman survived Auschwitz—Now she’s sharing her story on TikTok

Visitors routinely overwhelm Tova Friedman's TikTok account with tough questions, such as: Why didn't she try to flee Auschwitz? Could she hear screams coming ...

Read More